Výsledky vyhledávání - "Vinni Juneja"

Palmar-plantar erythrodysesthesia in patients receiving capecitabine and intratumor thymidine phosphorylase and dihydropyrimidine dehydrogenase: is there a pharmacologic explanation?

Autor: Vinni Juneja, Jennifer Thronton, Robert B. Diasio, Muhammad Wasif Saif, Glenda Black, Martin R. Johnson

Publikováno v: Supportive cancer therapy. 4(4)

Background Palmar-plantar erythordysesthesia (PPE) is the most common toxicity of capecitabine. Preclinical studies have shown that radiation therapy (RT) upregulates thymidine phosphorylase (TP), which could in turn increase the efficacy of capecita

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e0091ce89ce012aada1c475797a7d7
https://pubmed.ncbi.nlm.nih.gov/18632519

Zobrazit plný text záznamu

Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer

Autor: Yuan Li Shen, Kyung Y. Lee, Joseph E. Gootenberg, Mark D. Rothmann, Richard Pazdur, Karen D. Weiss, Patricia Keegan, Vinni Juneja

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 14(11)

Purpose: Erythropoiesis-stimulating agents (ESA) are approved for the treatment of anemia in patients with nonmyeloid malignancies whose anemia is due to the effect of concomitantly administered chemotherapy. Since the 1993 approval of epoetin alfa i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439ebeb692ee5294fcc843fadbb738b0
https://pubmed.ncbi.nlm.nih.gov/18519748

Zobrazit plný text záznamu

Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer

Autor: Michael Reiss, Daniel Zelterman, Rebecca Sipples, Vinni Juneja, Frans J. Th. Wackers, Bruce G. Haffty, Forrester A. Lee, Maysa M. Abu-Khalaf, Michael P. DiGiovanna, Meghan McGurk, Gina G. Chung, Barbara Burtness

Publikováno v: Breast cancer research and treatment. 104(3)

This study evaluated the incidence of late cardiotoxicity after dose-dense and -intense adjuvant sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) for breast cancer (BC) with ≥ 4 involved ipsilateral axillary lymph nodes. Patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3bbefc14f7fd3557c2af266a6e8576
https://pubmed.ncbi.nlm.nih.gov/17051423

Zobrazit plný text záznamu

Akademický článek

Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.

Autor: Maysa Abu-Khalaf, Vinni Juneja, Gina Chung, Michael DiGiovanna, Rebecca Sipples, Meghan McGurk, Daniel Zelterman, Bruce Haffty, Michael Reiss, Frans Wackers, Forrester Lee, Barbara Burtness

Publikováno v: Breast Cancer Research & Treatment; Sep2007, Vol. 104 Issue 3, p341-349, 9p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání